Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: Reprocessed EP catheters recalled due to contamination risk

News You Need to Know Today
News Alert: Reprocessed EP catheters recalled due to contamination risk
Tuesday, February 10, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

Reprocessed EP catheters recalled due to contamination risk

The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Reprocessed EP catheters recalled due to contamination risk

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Breaking News: AstraZeneca COVID-19 vaccine associated with risk of rare, potentially fatal blood clots
AI uses X-rays to predict mortality | 3 key ways COVID-19 changed patient care | Abbott's newest approval
Acute Coronary Syndromes: Why fish oil isn't always beneficial | A key discovery | PTSD & heart attack risk
Beta-blockers among people with HIV | Practice sues health system for $50M | Apple hiring a cardiologist
Excess deaths in the US up 23% | New study highlights the importance of TAVR | A new FDA approval for alirocumab
Week in Review: Beta-blockers inferior to other therapies | Processed meat & CVD risk | FDA approves Harmony TPV
Processed meat & CVD risk | ACC's new president | Dapagliflozin benefits both male & female HF patients

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …287
    • Page 288
    • Page 289
    • Page 290
    • Current page 291
    • Page 292
    • Page 293
    • Page 294
    • Page 295 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup